News and Trends 25 Jul 2023
Crescendo Biologics raises $32M and expands cancer trial
Crescendo Biologics Ltd, a clinical stage immuno-oncology company developing novel, targeted T cell enhancing therapeutics, has announced that it plans to augment the ongoing phase 1b clinical trial of CB307…